Background. The rapid development and universal access to vaccines represent a
milestone in combating the coronavirus disease 2019 (COVID-19) pandemic. However …

Background Evidence has demonstrated inferior humoral immune responses after SARS-
CoV-2 vaccination in kidney transplant recipients compared to the general population …

New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical
implications. We describe the first cases of an independently acquired V792I RNA …

Transplant recipients display poor responses to SARS‐CoV‐2 mRNA vaccines. In this
retrospective study, we investigate torque teno virus (TTV) viral load (VL), a ubiquitous virus …

Background Patients with chronic kidney disease (CKD) or kidney replacement therapy
demonstrate lower antibody levels after severe acute respiratory syndrome coronavirus 2 …

Vaccination is crucial for avoiding infection-associated morbidity and mortality among
immunocompromised patients. However, immunocompromised patients respond less well to …

Haemodialysis patients respond poorly to vaccination and continue to be at-risk for severe
COVID-19. Therefore, dialysis patients were among the first for which a fourth COVID-19 …

Kidney transplant recipients (KTRs) show poorer response to SARS-CoV-2 mRNA
vaccination, yet response patterns and mechanistic drivers following third doses are ill …

Introduction We investigated humoral and T-cell responses within 12 months after first
BNT162b2 vaccine in solid organ transplant (SOT) recipients and controls who had received …

Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody …